Avalon Investment & Advisory Regeneron Pharmaceuticals, Inc. Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Avalon Investment & Advisory holds 13,831 shares of REGN stock, worth $9.71 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

13,831

Holding current value

$9.71 Million

% of portfolio

0.32%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $9.41 Million - $11.4 Million	13,831 New	13,831 $11.4 Million
Q2 2021 Jul 29, 2021	SELL	$472.8 - $558.54 $366,420 - $432,868	-775 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $330,133 - $405,119	-739 Reduced 48.81%	775 $367,000
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $431,426 - $548,397	-902 Reduced 37.33%	1,514 $731,000
Q3 2020 Nov 04, 2020	BUY	$544.75 - $658.21 $99,144 - $119,794	182 Added 8.15%	2,416 $1.35 Million
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $214,594 - $280,105	435 Added 24.18%	2,234 $1.39 Million
Q1 2020 May 05, 2020	SELL	$336.18 - $494.43 $17,145 - $25,215	-51 Reduced 2.76%	1,799 $878,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $15,860 - $18,466	-58 Reduced 3.04%	1,850 $513,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $1,797 - $2,488	-6 Reduced 0.31%	1,908 $597,000
Q1 2019 Apr 24, 2019	SELL	$372.08 - $439.57 $37,208 - $43,957	-100 Reduced 4.97%	1,914 $786,000
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $2,014 - $2,418	-6 Reduced 0.3%	2,014 $752,000
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $22,768 - $27,599	-80 Reduced 3.81%	2,020 $697,000
Q1 2018 Jun 26, 2018	SELL	$315.82 - $393.78 $5.61 Million - $6.99 Million	-17,760 Reduced 89.43%	2,100 $723,000
Q1 2018 Jun 22, 2018	BUY	$315.82 - $393.78 $5.61 Million - $6.99 Million	17,760 Added 845.71%	19,860 $7.47 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $5.61 Million - $6.99 Million	-17,760 Reduced 89.43%	2,100 $723,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $15,062 - $19,737	42 Added 0.21%	19,860 $7.47 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $8.51 Million - $9.94 Million	-19,720 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	19,720	19,720 $9.69 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Regeneron Pharmaceuticals, Inc. Transaction History